• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION 6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number C610134
Medical Device Problem Code Activation Failure (3270)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/10/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Explanted date: device was not explanted.Explanted date: device was not explanted.The actual device was not returned for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.A review of the device history record of the product code/lot# combination was conducted with no findings.
 
Event or Problem Description
The user facility reported the angio-seal evolution device came out of the body during pullback.The procedure performed was a neuro intervention using a 6 fr sheath.The condition of the patient was good.Manual pressure was held, and the closure device was not placed.There was no patient injury, medical/surgical intervention required.Additional information was received on 13may2021: there were no difficulties with arterial access, sheath, guidewire, or catheter insertion.A pre deployment angiogram was performed.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to provide the completed investigation results.The actual device was not returned; therefore, an evaluation of the actual device was unable to be conducted.The complaint could not be confirmed.Since the product was not available for evaluation, the exact root cause of the allegation could not be determined.The dhr review determined that there were no manufacturing issues and the device was released in a conforming state.No ncs or capas have been noted for this failure mode.Currently, no action is recommended since this risk evaluation is within the predetermined limits in the fmea.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
6F ANGIO-SEAL EVOLUTION VASCULAR CLOSURE DEVICE, US
Common Device Name
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
2101 cottontail ln.
somerset NJ 08873
MDR Report Key11921934
Report Number2243441-2021-00023
Device Sequence Number3201823
Product Code MGB
UDI-Device Identifier00389701011783
UDI-Public00389701011783
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P930038
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2022
Device Catalogue NumberC610134
Device Lot Number7834529
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 05/11/2021
Supplement Date Received by Manufacturer06/29/2021
Initial Report FDA Received Date06/02/2021
Supplement Report FDA Received Date06/30/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-